Documentation Centre

October 18, 2010
Increased whole-body adiposity without a concomitant increase in liver fat is not associated with augmented metabolic dysfunction. Obesity 2010;18:1510-5
Magkos F, Fabbrini E, Mohammed BS, Patterson BW, Klein S.

Description of this Publication

The objective of this study was to investigate whether an increase in total adiposity, without a concomitant increase in intrahepatic triglyceride (IHTG) content is associated with metabolic complications. For that purpose, 10 subjects with class I obesity [body mass index (BMI) 30.0-34.9 kg/m2] were matched with 10 subjects with class III obesity (BMI≥40 kg/m2) on the basis of age, sex, and IHTG content. The analysis revealed that despite considerable differences in BMI, body fat mass (measured by dual-energy x-ray absorptiometry) and intra-abdominal (visceral) adipose tissue mass (measured at L4-L5 by magnetic resonance imaging) there were no signficant differences in liver, skeletal muscle, and adipose tissue insulin sensitivity or VLDL metabolism between groups matched on IHTG content. These results suggest that the increase in metabolic dysfunction associated with an increase in whole-body adiposity and BMI does not occur without a concomitant increase in liver fat.

Consult publication on external website

By clicking on this link, you will leave the INTERNATIONAL CHAIR ON CARDIOMETABOLIC RISK website

Key Words
Ectopic Fat, Insulin Resistance, Obesity